-
South Africa declares national disaster as floods batter region
-
Gang members in Guatemala kill seven police after prison crackdown: minister
-
Villa's title bid rocked by Everton loss, Newcastle held at Wolves
-
Dybala boosts Roma's Champions League hopes, Fiorentina honour Commisso
-
Villa's title bid rocked by Everton loss, Newcastle held by Wolves
-
'Avatar: Fire and Ash' at number one in N.America for fifth straight week
-
Limited internet returns in Iran after protest blackout
-
Syria's leader agrees truce deal with Kurds after govt troops advance
-
Smith's penalty sees Quins eliminate La Rochelle, Bordeaux secure top seeding
-
Atletico edge Alaves to strengthen Liga top-four hold
-
Uganda president says opposition 'terrorists' in victory speech
-
New Zealand register first ODI series win in India despite Kohli ton
-
Elvira wins Dubai Invitational after Lowry's last hole meltdown
-
Jeong snatches Union late draw at Stuttgart in Bundesliga
-
Man Utd's Martinez hits back at Scholes after height jibes
-
Frank on the brink as Romero calls for unity amid Spurs 'disaster'
-
Chile declares emergency as wildfires kill at least 15
-
Europe hits back at Trump tariff threat over Greenland
-
Men's Fashion Week in Paris: what to watch
-
McGrath goes top of slalom standings with Wengen win
-
No Venus fairytale as Alcaraz, Sabalenka win Melbourne openers
-
Iran considers 'gradually' restoring internet after shutdown
-
Mitchell, Phillips tons guide New Zealand to 337-8 in ODI decider
-
Flailing Frankfurt sack coach Toppmoeller
-
Kurdish forces withdraw from Syria's largest oil field as govt forces advance
-
'Proud' Venus Williams, 45, exits Australian Open after epic battle
-
Vonn in Olympic form with another World Cup podium in Tarvisio super-G
-
Alcaraz kicks off career Grand Slam bid with tough Australian Open test
-
Hosts Morocco face Mane's Senegal for AFCON glory
-
Europe scrambles to respond to Trump tariff threat
-
Venus Williams, 45, exits Australian Open after epic battle
-
Taiwan's Lin wins India Open marred by 'dirty' conditions
-
Indonesia rescuers find body from plane crash
-
Kurdish-led forces withdraw from Syria's largest oil field: monitor
-
Ball girl collapses in Australian Open heat as players rush to help
-
France's Moutet booed for underarm match point serve in Melbourne
-
Zverev happy with response after wobble in opening Melbourne win
-
'Bring it on': UK's Labour readies for EU reset fight
-
New Zealand's Wollaston wins again to lead Tour Down Under
-
Zverev wobbles but wins at Australian Open as Alcaraz enters fray
-
British qualifier upsets 20th seed Cobolli to make mum proud
-
Zverev drops set on way to Australian Open second round
-
Indonesian rescuers find debris from missing plane
-
Wembanyama scores 39 as Spurs overcome Edwards, Wolves in thriller
-
Heartbreak for Allen as Broncos beat Bills in playoff thriller
-
British qualifier upsets 20th seed Cobolli in Melbourne
-
Paolini races into round two to kickstart Australian Open
-
Portugal presidential vote wide open as far-right surge expected
-
Lutz kicks Broncos to overtime thriller as Bills, Allen fall short
-
Marchand closes Austin Pro Swim with 200m breaststroke win
Brazilian ritual root gets second life as potential anti-depressant
Long used in Indigenous Brazilian rituals, the jurema preta plant, which contains a potent psychedelic, is gaining ground as a potential treatment for depression.
At street stalls where medicinal herbs are sold, customers can buy the plant's root which contains dimethyltryptamine (DMT), a hallucinogenic substance that researchers say could be used to alleviate symptoms.
Following instructions he found on the internet, Guaracy Carvajal extracted DMT at home in 2016 from roots he bought on the street.
The 31-year-old software programmer, who had tried various treatment for chronic depression he has suffered since adolescence, said the drug makes it "feel like you've solved something in your life."
Physicist Draulio Araujo, who has conducted extensive research on the drug, said "the response is rapid. One day after treatment, (patients) already showed a significant improvement in their depression symptoms."
Yet he also warned that it "is not a magic cure" and that psychedelics "are not for everyone."
As a researcher at the Brain Institute of the Federal University of Rio Grande do Norte, Araujo and his team treated 14 people with the drug for six months.
The patients inhaled vaporized DMT, under medical supervision.
"It's common for our patients to say that something changed, that a key opened something," he said.
His patients also received psychological therapy, and some continued with conventional pharmaceutical drugs.
Neuroscientist Fernanda Palhano-Fontes, also of the Brain Institute, said "we have patients who improve significantly, others who don't improve at all."
Araujo's findings were published in the scientific journal Nature in April. In 2024, he published another study with promising results in the journal Psychedelic Medicine.
As for Carvajal, who stopped using jurema preta some time ago, he said the drug really allows a person to "start to have a lighter life."
It helped him get through a time when he was in "a state of questioning myself" about "work, day-to-day life," he said.
- Spiritual channels -
Brazil occupies a fairly prominent place in DMT research due to the substance's prominence in society, Araujo said.
While there is no ban on the cultivation or possession of jurema, which is also known as Mimosa tenuiflora, consumption of DMT is prohibited, except for religious and scientific use.
Jurema's roots are combined with other plants in a wine-like beverage that is consumed at rituals that include dancing and drums, part of Indigenous tradition in northeast Brazil where the plant grows.
"It's not hallucination," said Joyce Souza, a young woman attending a jurema ceremony in Planaltina, on the outskirts of Brasília.
"My spiritual channels become more accessible, I can communicate better with myself," Souza said.
Gathered in a house courtyard and dressed in white, the group of mostly novices waited for more seasoned practitioners to enter a trance and bring messages from ancient spirits.
Meanwhile, back in the lab, Araujo is hoping to expand his DMT research to a study of 100 patents.
"Let's say that in five years we'll have... a clear picture on when it will reach a real clinical setting," he said.
S.Gantenbein--VB